Facebook
Twitter
Telegram
Report an ErrorLigand Pharmaceuticals Incorporated General and Administrative Expenses 2011-2024 | LGND
Annual General and Administrative Expenses Ligand Pharmaceuticals Incorporated
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 52.8 M | 70.1 M | 46.8 M | 60 M | 41.9 M | 37.7 M | 28.7 M | 26.6 M | 24.4 M | 22.6 M | 18 M | 16.1 M | 15 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 70.1 M | 15 M | 35.4 M |
Quarterly General and Administrative Expenses Ligand Pharmaceuticals Incorporated
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 11 M | - | 14.7 M | 11.3 M | 10.9 M | - | 14.9 M | 12.1 M | 11.9 M | - | 12.7 M | 14.7 M | 12.6 M | - | 15 M | 10.1 M | 9.26 M | - | 9.52 M | 11 M | 11.1 M | - | 9.63 M | 9.29 M | 7.64 M | - | 7.03 M | 6.55 M | 7.32 M | - | 6.55 M | 7.24 M | 7.07 M | - | 4.97 M | 7.22 M | 5.99 M | - | 6.74 M | 5.24 M | 5.07 M | - | 4.76 M | 4.31 M | 4.5 M | - | 4.31 M | 3.86 M | 3.42 M | - | 3.96 M | 3.86 M | 3.44 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 15 M | 3.42 M | 8.32 M |